Abstract
We report a case of successful pregnancy after rituximab in a patient with a history of in vitro fertilisation (IVF) failures and positive anti-cardiolipin antibody (ACA). Following a course of rituximab, her ACA became negative and she successfully conceived with IVF treatment. This is the first case in literature describing the use of rituximab therapy in this clinical scenario.
Similar content being viewed by others
References
The European IVF-monitoring programme (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Andersen AN, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG. Assisted reproductive technology in Europe, 2002 (2006) Results generated from European Registers by ESHRE. Hum Reprod 21(7):1680–1697. Epub 2006 Apr 3
Kutteh WH (1997) Antiphospholipid antibodies and reproduction. J Reprod Immunol 35(2):151–171
Hornstein MD, Davis OK, Massey JB, Paulson RJ, Collins JA (2000) Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertil Steril 73(2):330–333
Stern C, Chamley L, Norris H, Hale L, Baker HW (2003) A randomised, double-blind placebo controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 80(2):376–383
Empson M, Lassere M, Craig J, Scott J (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 18(2):CD002859
Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N (2006) The effects of rituximab treatment during pregnancy on a neonate. Haematologica 91:1426–1427
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ng, C.T., O’Neil, M., Walsh, D. et al. Successful pregnancy after rituximab in a women with recurrent in vitro fertilisation failures and anti-phospholipid antibody positive. Ir J Med Sci 178, 531–533 (2009). https://doi.org/10.1007/s11845-008-0265-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-008-0265-5